N-[4-[2-[2-[(4-aminocyclohexyl)amino]pyrimidin-5-yl]ethyl]-3-methylphenyl]-2-chlorobenzenesulfonamide
C25H30ClN5O2S — CID 147822717
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[4-[2-[2-[(4-aminocyclohexyl)amino]pyrimidin-5-yl]ethyl]-3-methylphenyl]-2-chlorobenzenesulfonamide
N-[4-[2-[2-[(4-aminocyclohexyl)amino]pyrimidin-5-yl]ethyl]-3-methylphenyl]-2-chlorobenzenesulfonamide (PubChem CID 147822717) has the molecular formula C25H30ClN5O2S and a molecular weight of 500.07 g/mol. Its IUPAC name is N-[4-[2-[2-[(4-aminocyclohexyl)amino]pyrimidin-5-yl]ethyl]-3-methylphenyl]-2-chlorobenzenesulfonamide.
Molecular Properties
| Compound Name | N-[4-[2-[2-[(4-aminocyclohexyl)amino]pyrimidin-5-yl]ethyl]-3-methylphenyl]-2-chlorobenzenesulfonamide |
|---|---|
| PubChem CID | 147822717 |
| Molecular Formula | C25H30ClN5O2S |
| Molecular Weight | 500.07 g/mol |
| Exact Mass | 499.18 |
| IUPAC Name | N-[4-[2-[2-[(4-aminocyclohexyl)amino]pyrimidin-5-yl]ethyl]-3-methylphenyl]-2-chlorobenzenesulfonamide |
| SMILES | Cc1cc(NS(=O)(=O)c2ccccc2Cl)ccc1CCc1cnc(NC2CCC(N)CC2)nc1 |
| InChI | InChI=1S/C25H30ClN5O2S/c1-17-14-22(31-34(32,33)24-5-3-2-4-23(24)26)11-8-19(17)7-6-18-15-28-25(29-16-18)30-21-12-9-20(27)10-13-21/h2-5,8,11,14-16,20-21,31H,6-7,9-10,12-13,27H2,1H3,(H,28,29,30) |
| InChIKey | HPNXYBQZFSJNLD-UHFFFAOYSA-N |
| XLogP | 4.71 |
| TPSA | 110.00 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 34 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 500.07 |
| LogP ≤ 5 | 4.71 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 147822717 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.